fingolimod hydrochloride has been researched along with Central Serous Retinopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Albanese, M; Barbano, L; De Geronimo, D; Giorno, P; Landi, D; Marfia, GA; Parisi, V; Parravano, M; Ziccardi, L | 1 |
| Benita, D; Deb, AK; Pratima, GC; Sarkar, S | 1 |
| Foroozan, R; Khimani, KS | 1 |
3 other study(ies) available for fingolimod hydrochloride and Central Serous Retinopathy
| Article | Year |
|---|---|
Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Indocyanine Green; Male; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Tomography, Optical Coherence; Visual Acuity | 2021 |
Fingolimod-associated central serous chorioretinopathy in a young girl.
Topics: Adult; Central Serous Chorioretinopathy; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2021 |
Central Serous Chorioretinopathy Associated With Fingolimod Treatment.
Topics: Administration, Oral; Adult; Central Serous Chorioretinopathy; Choroid; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Retina; Tomography, Optical Coherence; Visual Acuity | 2018 |